Cargando…

Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX

BACKGROUND: In recent years attention has focused on γH2AX as a very sensitive double strand break indicator. It has been suggested that γH2AX might be able to predict individual radiosensitivity. Our aim was to study the induction and repair of DNA double strand breaks labelled by γH2AX in a large...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroeber, Jana, Wenger, Barbara, Schwegler, Manuela, Daniel, Christoph, Schmidt, Manfred, Djuzenova, Cholpon S, Polat, Bülent, Flentje, Michael, Fietkau, Rainer, Distel, Luitpold V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330982/
https://www.ncbi.nlm.nih.gov/pubmed/25889915
http://dx.doi.org/10.1186/s13014-015-0344-5
_version_ 1782357658815168512
author Kroeber, Jana
Wenger, Barbara
Schwegler, Manuela
Daniel, Christoph
Schmidt, Manfred
Djuzenova, Cholpon S
Polat, Bülent
Flentje, Michael
Fietkau, Rainer
Distel, Luitpold V
author_facet Kroeber, Jana
Wenger, Barbara
Schwegler, Manuela
Daniel, Christoph
Schmidt, Manfred
Djuzenova, Cholpon S
Polat, Bülent
Flentje, Michael
Fietkau, Rainer
Distel, Luitpold V
author_sort Kroeber, Jana
collection PubMed
description BACKGROUND: In recent years attention has focused on γH2AX as a very sensitive double strand break indicator. It has been suggested that γH2AX might be able to predict individual radiosensitivity. Our aim was to study the induction and repair of DNA double strand breaks labelled by γH2AX in a large cohort. METHODS: In a prospective study lymphocytes of 136 rectal cancer (RC) patients and 59 healthy individuals were ex vivo irradiated (IR) and initial DNA damage was compared to remaining DNA damage after 2 Gy and 24 hours repair time and preexisting DNA damage in unirradiated lymphocytes. Lymphocytes were immunostained with anti-γH2AX antibodies and microscopic images with an extended depth of field were acquired. γH2AX foci counting was performed using a semi-automatic image analysis software. RESULTS: Distinct increased values of preexisting and remaining γH2AX foci in the group of RC patients were found compared to the healthy individuals. Additionally there are clear differences within the groups and there are outliers in about 12% of the RC patients after ex vivo IR. CONCLUSIONS: The γH2AX assay has the capability to identify a group of outliers which are most probably patients with increased radiosensitivity having the highest risk of suffering radiotherapy-related late sequelae.
format Online
Article
Text
id pubmed-4330982
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43309822015-02-18 Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX Kroeber, Jana Wenger, Barbara Schwegler, Manuela Daniel, Christoph Schmidt, Manfred Djuzenova, Cholpon S Polat, Bülent Flentje, Michael Fietkau, Rainer Distel, Luitpold V Radiat Oncol Research BACKGROUND: In recent years attention has focused on γH2AX as a very sensitive double strand break indicator. It has been suggested that γH2AX might be able to predict individual radiosensitivity. Our aim was to study the induction and repair of DNA double strand breaks labelled by γH2AX in a large cohort. METHODS: In a prospective study lymphocytes of 136 rectal cancer (RC) patients and 59 healthy individuals were ex vivo irradiated (IR) and initial DNA damage was compared to remaining DNA damage after 2 Gy and 24 hours repair time and preexisting DNA damage in unirradiated lymphocytes. Lymphocytes were immunostained with anti-γH2AX antibodies and microscopic images with an extended depth of field were acquired. γH2AX foci counting was performed using a semi-automatic image analysis software. RESULTS: Distinct increased values of preexisting and remaining γH2AX foci in the group of RC patients were found compared to the healthy individuals. Additionally there are clear differences within the groups and there are outliers in about 12% of the RC patients after ex vivo IR. CONCLUSIONS: The γH2AX assay has the capability to identify a group of outliers which are most probably patients with increased radiosensitivity having the highest risk of suffering radiotherapy-related late sequelae. BioMed Central 2015-02-11 /pmc/articles/PMC4330982/ /pubmed/25889915 http://dx.doi.org/10.1186/s13014-015-0344-5 Text en © Kroeber et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kroeber, Jana
Wenger, Barbara
Schwegler, Manuela
Daniel, Christoph
Schmidt, Manfred
Djuzenova, Cholpon S
Polat, Bülent
Flentje, Michael
Fietkau, Rainer
Distel, Luitpold V
Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX
title Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX
title_full Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX
title_fullStr Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX
title_full_unstemmed Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX
title_short Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX
title_sort distinct increased outliers among 136 rectal cancer patients assessed by γh2ax
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330982/
https://www.ncbi.nlm.nih.gov/pubmed/25889915
http://dx.doi.org/10.1186/s13014-015-0344-5
work_keys_str_mv AT kroeberjana distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT wengerbarbara distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT schweglermanuela distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT danielchristoph distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT schmidtmanfred distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT djuzenovacholpons distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT polatbulent distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT flentjemichael distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT fietkaurainer distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax
AT distelluitpoldv distinctincreasedoutliersamong136rectalcancerpatientsassessedbygh2ax